|
The U.S. Food and Drug Administration posted Advancing Health through Innovation: New Drug Therapy Approvals 2020, a summary of the Center for Drug Evaluation and Research’s (CDER’s) novel drugs and other notable drug therapy approvals of 2020.
These new approvals will benefit patients affected by a multitude of medical conditions including infectious diseases such as COVID-19, neurological conditions, cancers, and a wide range of rare diseases.
|
